Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Apixaban, sold under the brand name Eliquis among others, is an anticoagulant medication used to treat and prevent blood clots and to prevent stroke in people with nonvalvular atrial fibrillation through directly inhibiting factor Xa. It is used as an alternative to warfarin to prevent blood clots following hip or knee replacement and in those with a…
History, Community, Culture & Applications
Explore the main themes, entities and connections around Apixaban. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
bleeding people embolism risk may use stroke atrial fibrillation approved factor xa united states warfarin side us pfizer direct blood
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Apixaban | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Apixaban | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Apixaban | ATC code | B01AF02 (WHO) | 1.00 | infobox |
| Apixaban | Bioavailability | ~50% | 1.00 | infobox |
| Apixaban | CAS Number | 503612-47-3 Y | 1.00 | infobox |
| Apixaban | ChEMBL | ChEMBL231779 Y | 1.00 | infobox |
| Apixaban | ChemSpider | 8358471 Y | 1.00 | infobox |
| Apixaban | CompTox Dashboard (EPA) | DTXSID80436500 | 1.00 | infobox |
| Apixaban | DrugBank | DB07828 Y | 1.00 | infobox |
| Apixaban | ECHA InfoCard | 100.167.332 | 1.00 | infobox |
| Apixaban | Elimination half-life | 9–14 h | 1.00 | infobox |
| Apixaban | Excretion | Bile duct (75%), kidney (25%) | 1.00 | infobox |
| Apixaban | Formula | C25H25N5O4 | 1.00 | infobox |
| Apixaban | IUPHAR/BPS | 6390 | 1.00 | infobox |
| Apixaban | KEGG | D03213 Y | 1.00 | infobox |
| Apixaban | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Apixaban | Legal status | CA: ℞-only | 1.00 | infobox |
| Apixaban | Legal status | UK: POM (Prescription only) | 1.00 | infobox |
| Apixaban | Legal status | US: ℞-only | 1.00 | infobox |
| Apixaban | Legal status | EU: Rx-only | 1.00 | infobox |
| Apixaban | Legal status | In general: ℞ (Prescription only) | 1.00 | infobox |
| Apixaban | License data | US DailyMed: Apixaban | 1.00 | infobox |
| Apixaban | MedlinePlus | a613032 | 1.00 | infobox |
| Apixaban | Metabolism | CYP3A4, CYP3A5, CYP1A2 and others | 1.00 | infobox |
| Apixaban | Molar mass | 459.506 g·mol−1 | 1.00 | infobox |
| Apixaban | Other names | BMS-562247-01 | 1.00 | infobox |
| Apixaban | Pregnancy category | AU: C | 1.00 | infobox |
| Apixaban | Protein binding | ~87% | 1.00 | infobox |
| Apixaban | PubChem CID | 10182969 | 1.00 | infobox |
| Apixaban | Routes of administration | By mouth | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.